Takeda reported JPY418.53B in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
Astellas Pharma JPY 244.7B 36.91B Jun/2026
Chugai Pharma JPY 382.3B 8.13B Sep/2026
Daiichi Sankyo JPY 637.85B 188.04B Jun/2026
Eisai JPY 245.42B 56.22B Mar/2026
Kyowa Hakko Kirin JPY 249.52B 30.75B Mar/2026
M3 JPY 162.17B 6B Jun/2026
Otsuka Holdings JPY 472.49B 2.94B Sep/2026
Shionogi JPY 298.94B 412.46B Jun/2026
Sumitomo Dainippon JPY 76.6B 32.29B Jun/2026
Takeda JPY 418.53B 42.45B Sep/2026
Terumo JPY 314.63B 34.14B Jun/2026